Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.0%, driven by a pullback from Illumina of 7.7%. In contrast, Alpha Teknova has gained 29%. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 16% per annum.
Has the U.S. Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 26 Sep 2023 | US$674.7b | US$154.6b | US$11.2b | 33.7x | 60.2x | 4.4x |
Thu, 24 Aug 2023 | US$713.3b | US$154.6b | US$11.2b | 32.8x | 63.6x | 4.6x |
Sat, 22 Jul 2023 | US$741.4b | US$155.5b | US$12.7b | 29.4x | 58.4x | 4.8x |
Mon, 19 Jun 2023 | US$704.3b | US$152.4b | US$12.5b | 29.3x | 56.3x | 4.6x |
Wed, 17 May 2023 | US$672.0b | US$152.4b | US$12.6b | 28.2x | 53.2x | 4.4x |
Fri, 14 Apr 2023 | US$744.3b | US$154.6b | US$10.8b | 30.7x | 68.9x | 4.8x |
Sun, 12 Mar 2023 | US$693.6b | US$154.5b | US$10.9b | 29.6x | 63.9x | 4.5x |
Tue, 07 Feb 2023 | US$758.4b | US$155.7b | US$9.1b | 31.5x | 83.3x | 4.9x |
Thu, 05 Jan 2023 | US$734.2b | US$155.2b | US$8.8b | 28.9x | 83.7x | 4.7x |
Sat, 03 Dec 2022 | US$781.0b | US$155.1b | US$8.8b | 28.9x | 89x | 5x |
Mon, 31 Oct 2022 | US$720.5b | US$154.5b | US$13.0b | 27x | 55.6x | 4.7x |
Wed, 28 Sep 2022 | US$699.1b | US$152.2b | US$17.3b | 23.8x | 40.4x | 4.6x |
Fri, 26 Aug 2022 | US$803.5b | US$152.2b | US$17.3b | 31.1x | 46.4x | 5.3x |
Sun, 24 Jul 2022 | US$787.5b | US$148.7b | US$20.2b | 32.1x | 39x | 5.3x |
Tue, 21 Jun 2022 | US$674.6b | US$148.1b | US$20.1b | 27.5x | 33.6x | 4.6x |
Thu, 19 May 2022 | US$731.6b | US$148.0b | US$20.0b | 31.5x | 36.5x | 4.9x |
Sat, 16 Apr 2022 | US$839.5b | US$146.5b | US$25.3b | 36.4x | 33.1x | 5.7x |
Mon, 14 Mar 2022 | US$792.0b | US$145.3b | US$25.2b | 33.5x | 31.5x | 5.5x |
Wed, 09 Feb 2022 | US$859.1b | US$139.8b | US$26.9b | 38.8x | 31.9x | 6.1x |
Fri, 07 Jan 2022 | US$916.3b | US$138.0b | US$27.3b | 42.6x | 33.5x | 6.6x |
Sun, 05 Dec 2021 | US$942.0b | US$138.0b | US$27.3b | 43.1x | 34.5x | 6.8x |
Tue, 02 Nov 2021 | US$766.1b | US$107.8b | US$21.5b | 49.2x | 35.6x | 7.1x |
Thu, 30 Sep 2021 | US$720.1b | US$105.9b | US$18.6b | 48.7x | 38.6x | 6.8x |
Sat, 28 Aug 2021 | US$727.9b | US$105.8b | US$18.7b | 52x | 39x | 6.9x |
Sun, 04 Jul 2021 | US$656.3b | US$101.0b | US$17.6b | 39.3x | 37.2x | 6.5x |
Wed, 07 Apr 2021 | US$569.5b | US$92.3b | US$15.4b | 38.8x | 37x | 6.2x |
Sat, 09 Jan 2021 | US$553.9b | US$89.0b | US$14.2b | 39x | 39x | 6.2x |
Fri, 02 Oct 2020 | US$450.0b | US$79.8b | US$11.8b | 38.6x | 38.2x | 5.6x |
38.2x
How does U.S. Clinical Research and Equipment compare with similar industries?
US Market | -2.69% | |
Healthcare | -1.09% | |
Life Sciences | -2.02% | |
Clinical Research and Equipment | -2.02% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
TKNO Alpha Teknova | US$2.31 | 29.1% +US$43.4m | -37.4% | PS2.4x | |
OLK Olink Holding | US$15.04 | 1.9% +US$34.8m | 18.4% | PS12.8x | |
BLFS BioLife Solutions | US$13.30 | 4.5% +US$24.8m | -38.4% | PS3.6x | |
SHC Sotera Health | US$15.39 | 0.4% +US$17.0m | 113.5% | PS4.5x | |
SLGC SomaLogic | US$2.34 | 2.6% +US$11.3m | -19.3% | PS4.3x |